Tomosynthesis plus mammography images take 47 percent longer for radiologists to interpret than digital mammography alone.
Adding tomosynthesis to mammography increases image interpretation time for screening examinations compared with time to interpret images from conventional digital mammography alone, according to a study published in the journal Radiology.
Researchers from Massachusetts General Hospital sought to determine the effect of implementing a screening tomosynthesis program, combining tomosynthesis and mammography, on interpretation times in the real world setting, compared with interpretation times for conventional screening mammography.
Ten radiologists were recruited to participate in the study, which took place from July 2012 to January 2013. They prospectively read 2,163 images from screening digital mammography and 1,502 of combined tomosynthesis and mammography examinations, for a total of 3,665 examinations.
The examinations took place in one-hour sessions and the radiologists participated in at least five sessions per modality. The number of cases reported during each session was recorded for each reader, as well as the level of the radiologist experience.
The findings showed that mean interpretation time was 2.8 minutes for the combined tomosynthesis and mammography studies and 1.9 minutes for mammography. This was a 47 percent increase in time to read the combined studies over the digital mammography.
“A mean of 10.2 fewer studies were interpreted per hour during combined tomosynthesis and mammography compared with digital mammography sessions,” the authors wrote. However, the more experienced the radiologist, the less additional time was required overall.
The authors concluded that the addition of tomosynthesis to mammography resulted in increased image interpretation compared with conventional digital mammography alone.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.